Panel I

1. Janet Woodcock, M.D.
   Director
   Center for Drug Evaluation and Research, Food and Drug Administration
   Silver Spring, MD
   • Adobe Acrobat DocumentDownload Testimony
2. Jeffrey Shuren, M.D., J.D.
   Director
   Center for Devices and Radiological Health, Food and Drug Administration
   Silver Spring, MD
   • Adobe Acrobat DocumentDownload Testimony

Panel II

1. David Wheadon, M.D.
   Senior Vice President of Scientific and Regulatory Affairs
   Pharmaceutical Research and Manufacturers of America
   Washington, DC
   • Adobe Acrobat DocumentDownload Testimony
2. Sara Radcliffe
   Executive Vice President
   Health, Biotechnology Industry Organization
   Washington, DC
   • Adobe Acrobat DocumentDownload Testimony
3. David R. Gaugh, R.Ph.
   Vice President for Regulatory Affairs
   Generic Pharmaceutical Association
   Washington, DC
   • Adobe Acrobat DocumentDownload Testimony
4. David Nexon, Ph.D.
   Senior Executive Vice President
   Advanced Medical Technology Association
   Washington, DC
   • Adobe Acrobat DocumentDownload Testimony
5. Allan Coukell, BScPharm
   Director of Medical Programs, The Pew Charitable Trusts
   Washington, DC
   • Adobe Acrobat DocumentDownload Testimony

• Click here to view the final hearing transcript as printed »